Todd M. Pitts Division of Oncology, School of Medicine University of Colorado Denver Anschutz Medical Campus Biography Publications Institution JoVE Articles Todd M. Pitts has not added a biography. If you are Todd M. Pitts and would like to personalize this page please email our Author Liaison for assistance. Publications Bitter Melon Juice Intake with Gemcitabine Intervention Circumvents Resistance to Gemcitabine in Pancreatic Patient-derived Xenograft Tumors Molecular Carcinogenesis. Oct, 2020 | Pubmed ID: 32816368 Evaluation of the Efficacy of Dasatinib, a Src/Abl Inhibitor, in Colorectal Cancer Cell Lines and Explant Mouse Model PloS One. 2017 | Pubmed ID: 29091939 A NOTCH1 Gene Copy Number Gain is a Prognostic Indicator of Worse Survival and a Predictive Biomarker to a Notch1 Targeting Antibody in Colorectal Cancer International Journal of Cancer. Jan, 2016 | Pubmed ID: 26152787 Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras-mutated Colorectal Cancer Molecular Cancer Therapeutics. Dec, 2010 | Pubmed ID: 20923857 Test d’immunothérapies anticancéreuses dans un modèle murin humanisé portant des tumeurs humaines Jordi M. Lanis*1, Matthew S. Lewis*1, Hannah Strassburger1, Kristina Larsen1, Stacey M. Bagby2, Adrian T. A. Dominguez2, Juan A. Marín-Jiménez3, Roberta Pelanda1, Todd M. Pitts2, Julie Lang1 1Department of Immunology and Microbiology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, 2Division of Oncology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, 3Department of Medical Oncology, Catalan Institute of Oncology (ICO-L'Hospitalet) JoVE 64606 Cancer Research Développement et maintenance d'une tumeur du patient Préclinique dérivé modèle de xénogreffe de l'enquête de Novel Anti-Cancer Therapies Stacey Bagby1, Wells A. Messersmith1, Todd M. Pitts1, Anna Capasso1, Marileila Varella-Garcia1, Peter J. Klauck1, Jihye Kim1, Aik-Choon Tan1, S. Gail Eckhardt1, John J. Tentler1, John Arcaroli1 1Medicine, University of Colorado Denver Anschutz Medical Campus JoVE 54393 Cancer Research
Test d’immunothérapies anticancéreuses dans un modèle murin humanisé portant des tumeurs humaines Jordi M. Lanis*1, Matthew S. Lewis*1, Hannah Strassburger1, Kristina Larsen1, Stacey M. Bagby2, Adrian T. A. Dominguez2, Juan A. Marín-Jiménez3, Roberta Pelanda1, Todd M. Pitts2, Julie Lang1 1Department of Immunology and Microbiology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, 2Division of Oncology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, 3Department of Medical Oncology, Catalan Institute of Oncology (ICO-L'Hospitalet) JoVE 64606 Cancer Research
Développement et maintenance d'une tumeur du patient Préclinique dérivé modèle de xénogreffe de l'enquête de Novel Anti-Cancer Therapies Stacey Bagby1, Wells A. Messersmith1, Todd M. Pitts1, Anna Capasso1, Marileila Varella-Garcia1, Peter J. Klauck1, Jihye Kim1, Aik-Choon Tan1, S. Gail Eckhardt1, John J. Tentler1, John Arcaroli1 1Medicine, University of Colorado Denver Anschutz Medical Campus JoVE 54393 Cancer Research